Archetype Therapeutics
Archetype Therapeutics is an AI-native biotechnology company pioneering patient-centric drug discovery by leveraging generative chemogenomics and patient clinicogenomic data. Their platform enables virtual screening of billions of drug-like molecules daily to identify candidates likely to improve clinical outcomes across multiple diseases including metastatic castration-resistant prostate cancer, early-stage lung adenocarcinoma, metastatic melanoma, and idiopathic pulmonary fibrosis. The company integrates deep learning and real-world patient data to bridge the translational gap between drug discovery and patient outcomes, accelerating drug development with a disease-agnostic approach and validated clinical trial predictions. Archetype collaborates broadly across healthcare and life sciences to rapidly develop patient-driven therapeutics, supported by a team with extensive expertise in genomics, AI, medicinal chemistry, and oncology.
Archetype Therapeutics
Archetype Therapeutics is an AI-native biotechnology company pioneering patient-centric drug discovery by leveraging generative chemogenomics and patient clinicogenomic data. Their platform enables virtual screening of billions of drug-like molecules daily to identify candidates likely to improve clinical outcomes across multiple diseases including metastatic castration-resistant prostate cancer, early-stage lung adenocarcinoma, metastatic melanoma, and idiopathic pulmonary fibrosis. The company integrates deep learning and real-world patient data to bridge the translational gap between drug discovery and patient outcomes, accelerating drug development with a disease-agnostic approach and validated clinical trial predictions. Archetype collaborates broadly across healthcare and life sciences to rapidly develop patient-driven therapeutics, supported by a team with extensive expertise in genomics, AI, medicinal chemistry, and oncology.